Registered entities
Innate Pharma, Sa
Reg. No. 1598599United States
Innovation
136 patent families (72 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 18,027 times.
| Year | Filings |
|---|---|
| 2015 | 24 |
| 2016 | 26 |
| 2017 | 34 |
| 2018 | 34 |
| 2019 | 43 |
| 2020 | 35 |
| 2021 | 28 |
| 2022 | 30 |
| 2023 | 34 |
| 2024 | 34 |
| 2025 | 27 |
| 2026 | 8 |
Social engagement
Social engagement: 31.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 29% |
| Private equity | 5 | 29% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 6 | 35% |
Recent activity
28 May 2026
Event
ASCO 2026 Annual Meeting
19 May 2026
Event
Jefferies Global Healthcare Conference 2026
13 May 2026
Event
Q1 Financial Results and Business Update